Výsledky vyhledávání - "Antti Nätynki"

Akademický článek

Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients

Autor: Antti Nätynki, Päivi Leisti, Jussi Tuusa, Outi Varpuluoma, Laura Huilaja, Kentaro Izumi, Sanna-Kaisa Herukka, Olavi Ukkola, Juhani Junttila, Nina Kokkonen, Kaisa Tasanen

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

The use of dipeptidyl peptidase 4 (DPP4) inhibitors, (also known as gliptins), is associated with an increased risk of bullous pemphigoid (BP), an autoimmune blistering skin disease. To explore the mechanism behind gliptin-associated BP we investigat

Externí odkaz: https://doaj.org/article/d7f5e08f1fb840e0bb3ba84f768e5e58

Zobrazit plný text záznamu

Akademický článek

Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease

Autor: Antti Nätynki, Jussi Tuusa, Kaisa Hervonen, Katri Kaukinen, Outi Lindgren, Laura Huilaja, Nina Kokkonen, Teea Salmi, Kaisa Tasanen

Publikováno v: Frontiers in Immunology, Vol 11 (2020)

Dermatitis herpetiformis (DH) is an extraintestinal manifestation of coeliac disease (CD). Patients with DH have an elevated risk of development of another autoimmune blistering skin disease, bullous pemphigoid (BP). In this study we investigated whe

Externí odkaz: https://doaj.org/article/ead9348fb397495cb62bdb86936b0e9d

Zobrazit plný text záznamu

Akademický článek

CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells.

Autor: Mika Pietilä, Siri Lehtonen, Elina Tuovinen, Kaarina Lähteenmäki, Saara Laitinen, Hannu-Ville Leskelä, Antti Nätynki, Juha Pesälä, Katrina Nordström, Petri Lehenkari

Publikováno v: PLoS ONE, Vol 7, Iss 2, p e31671 (2012)

Human mesenchymal stem cells (hMSCs) display immunosuppressive properties in vitro and the potential has also been transferred successfully to clinical trials for treatment of autoimmune diseases. OX-2 (CD200), a member of the immunoglobulin superfam

Externí odkaz: https://doaj.org/article/ad08aae4cac149c496e2f344c16298e0

Zobrazit plný text záznamu

ESDR040 - Vildagliptin administration alters mouse skin proteome

Autor: Kaisa Tasanen, Ulrich Bergmann, Steffen Ohlmeier, Jussi Tuusa, Nina Kokkonen, Antti Nätynki

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ba229eea319b4bb9c13994390e4bb20
https://doi.org/10.26226/m.62fa008ef61b200019980ea8

Zobrazit plný text záznamu

CD200 Positive Human Mesenchymal Stem Cells Suppress TNF-Alpha Secretion from CD200 Receptor Positive Macrophage-Like Cells

Autor: Hannu Ville Leskelä, Saara Laitinen, Katrina Nordström, Mika Pietilä, Kaarina Lähteenmäki, Juha Pesälä, Antti Nätynki, Siri Lehtonen, Elina Tuovinen, Petri Lehenkari

Publikováno v: PLoS ONE
Europe PubMed Central
PLoS ONE, Vol 7, Iss 2, p e31671 (2012)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d71c282debc1c7e4f26a242fb4a1959
http://europepmc.org/articles/PMC3282758

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání